We first conducted a pan-cancer analysis of RPLP2 mRNA expression based on TCGA and GTEx databases, and the results indicated that RPLP2 significantly increased in 21 different types of cancer, especially in DLBCL (Figure 1A,B). This evidence concerns the gene RPLP2 and diffuse large B-cell lymphoma.